TRV GP V, LLC
An institutional investment manager in Boston, MA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 10, 2026. SEC CIK 1990717.
- Reported value$498.2m
- Positions3
Holdings: 3 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Rapport Therapeutics, Inc.RAPP | COM | 75383L102 | 262 | 52.5% | 6,280,525 | Reduced−854,708 | |
| Septerna, Inc.SEPN | COM | 81734D104 | 208 | 41.8% | 6,215,591 | Unchanged | |
| Maze Therapeutics, Inc.MAZE | COM | 578784100 | 28.4 | 5.7% | 950,800 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-340725 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.